Latest BioArctic News & Updates

See the latest news and media coverage for BioArctic. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
BioArctic

Research-oriented biopharma company for neurodegenerative diseases

bioarctic.com
Headquarters
Stockholm, Sweden
Founded year
2003
Company type
Public company
Number of employees
125–200

Last updated

Latest news about BioArctic

In short: BioArctic achieved record profitability in 2025 and secured a $30 million Novartis deal while expanding the global reach of Alzheimer's drug Leqembi.

Company announcements

Unlock all announcements with a

Media coverage

  • Dagens industri

    FDA extends Bioarctic review

    The pharmaceutical company Bioarctic's partner Eisai announces that the US pharmaceutical agency FDA has extended the review period by three months...

  • Dagens industri

    161 million in royalty for Bioarctic during the quarter

    The pharmaceutical company Bioarctic received preliminarily a royalty of 161 million kronor regarding the sales for Leqembi for the first quarter of 2026, according to...

  • Investing.com

    Goldman cuts BioArctic on valuation, competitive risks from Eli Lilly; shares down

    BioArctic shares fell about 5% on Tuesday after Goldman Sachs cut the stock to "neutral" from "buy," saying recent gains have narrowed upside to its...

  • Yahoo Finance

    BioArctic publishes the Annual Report and Sustainability Report for 2025

    STOCKHOLM, April 21, 2026 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announces that the Annual Report for 2025 has been published and is...

Unlock all articles with a

Never miss news about BioArctic

Track BioArctic and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

BioArctic competitors & trending companies

Browse news for competitors to BioArctic and other trending companies.